Initial Leukemia Research Program
A five-year intensive research program was established in 1997 supporting closely linked leukemia research projects in the hope that important finds would benefit all.
"What we accomplish together will touch the lives of many people affected by cancer. Our goals can only be achieved through intensive efforts at the highest level of excellence in medicine and science…Thank you for joining us in this important work." Paul A. Marks, MD, President Memorial Sloan-Kettering Cancer Centre, U.S.A.
top
Development of Leukemia Research Centers
Gabrielle Rich Center for Clinical Immunology and Transplant Biology, Weitzman Institute of Science, Israel
Bone marrow transplantation has been successfully used to combat leukemia, but the technique's success has required an exact donor match and suppression of the body's immune system. A new bone marrow transplantation technique developed by Weizmann Institute researchers does not depend on an exact donor match and is already in clinical application in Europe.
This technique has implications for:
 |
|
– |
Sickle-cell anemia, Gaucher's, Tay Sachs and other blood disorders |
|
|
– |
Autoimmune complications in lupus and diabetes |
|
|
– |
Malignancies involving solid tumors in breast cancer or melanoma |
|
|
– |
Organ transplants from mismatched human and animal donors |
|
|
– |
Reconstitution of the immune system of AIDS patients with HIV-resistant bone marrow |
top